Your browser doesn't support javascript.
loading
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer.
Masuhiro, Kentaro; Tamiya, Motohiro; Fujimoto, Kosuke; Koyama, Shohei; Naito, Yujiro; Osa, Akio; Hirai, Takashi; Suzuki, Hidekazu; Okamoto, Norio; Shiroyama, Takayuki; Nishino, Kazumi; Adachi, Yuichi; Nii, Takuro; Kinugasa-Katayama, Yumi; Kajihara, Akiko; Morita, Takayoshi; Imoto, Seiya; Uematsu, Satoshi; Irie, Takuma; Okuzaki, Daisuke; Aoshi, Taiki; Takeda, Yoshito; Kumagai, Toru; Hirashima, Tomonori; Kumanogoh, Atsushi.
Afiliación
  • Masuhiro K; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tamiya M; Department of Immunopathology, World Premier International Research Center, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Fujimoto K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Koyama S; Department of Immunology and Genomics, Graduate School of Medicine, Osaka City University, Osaka, Japan.
  • Naito Y; Division of Metagenome Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Osa A; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Hirai T; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan.
  • Suzuki H; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Okamoto N; Department of Immunopathology, World Premier International Research Center, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Shiroyama T; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nishino K; Department of Immunopathology, World Premier International Research Center, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Adachi Y; Department of Otorhinolaryngology-Head and Neck Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nii T; Department of Thoracic Oncology, Osaka Habikino Medical Center, Osaka, Japan.
  • Kinugasa-Katayama Y; Department of Thoracic Oncology, Osaka Habikino Medical Center, Osaka, Japan.
  • Kajihara A; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Morita T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Imoto S; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Uematsu S; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Irie T; Department of Cellular Immunology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Okuzaki D; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Aoshi T; Department of Immunopathology, World Premier International Research Center, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Takeda Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kumagai T; Department of Immunopathology, World Premier International Research Center, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Hirashima T; Division of Health Medical Intelligence, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kumanogoh A; Department of Immunology and Genomics, Graduate School of Medicine, Osaka City University, Osaka, Japan.
JCI Insight ; 7(9)2022 05 09.
Article en En | MEDLINE | ID: mdl-35389889

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: JCI Insight Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: JCI Insight Año: 2022 Tipo del documento: Article País de afiliación: Japón